Clinical Trials Directory

Trials / Unknown

UnknownNCT05864183

Screening for Risk Factors of Prediabetes Among Adult Patients at Sohag University Hospital

Screening for Risk Factors of Prediabetes Among Adults Patients at Sohag University Hospital

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

* Prediabetes is an intermediate state of hyperglycemia with glycemic parameters above normal but below the diabetes threshold.. * during the average 3 years of follow-up Prediabetes is diagnosed based on laboratory tests: fasting plasma glucose level (100-125 mg/dl) ;HbA1c, (5.7-6.4%) or plasma glucose level after an oral glucose tolerance test ( 140-199 mg/dl). * Reports estimate that more than 470 million people will have prediabetes by 2030. * According to an expert panel of the American Diabetes Association, up to 70% of individuals with prediabetes will eventually develop diabetes. * Observational evidence suggests as association between prediabetes and complications of diabetes such early nephropathy(10%) , small fiber neuropathy(18-25 %), early retinopathy (8-12%) and risk of macrovascular disease (52%) . * Screening for prediabetes is designed to save lives or enhance an individual's quality of life by early detection so that screening will minimize the risk of developing diabetes or its complications .

Detailed description

* In this case control study we aim to screen for risk factors of prediabetes among adult patients to minimize the risk of developing diabetes or its complications . * Prediabetes screening is also required to minimize medical costs such as hospitalization, outpatient care, surgery, medications, and laboratory test costs . * Several studies had shown efficacy of lifestyle interventions in diabetes prevention by targeting obesity with increase in physical activity and dietary changes with a relative risk reduction of 40%-70% in adults with prediabetes ,also there is increasing evidence to prove the efficacy of pharmacotherapy in prevention of diabetes in adults with prediabetes

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHbA1cHbA1c will be measured for all patients to minimize the risk of developing diabetes or its complications .
DIAGNOSTIC_TESTlipid profilelipid profile will be measured for all patients to minimize the risk of developing diabetes or its complications .
DIAGNOSTIC_TESTCBCCBC will be measured for all patients to minimize the risk of developing diabetes or its complications
DIAGNOSTIC_TESTAlb/cr ratioAlb/cr will be measured for all patients to minimize the risk of developing diabetes or its complications
DIAGNOSTIC_TESTserum creatinine .serum creatinine will be measured for all patients to minimize the risk of developing diabetes or its complications
DIAGNOSTIC_TESTCRPCRP will be measured for all patients to minimize the risk of developing diabetes or its complications
DIAGNOSTIC_TESTurine analysisurine analysis will be measured for all patients to minimize the risk of developing diabetes or its complications
DIAGNOSTIC_TESTECGECG will be done for all patients to minimize the risk of developing diabetes or its complications
DIAGNOSTIC_TESTfundus examinationfundus examination will be done for all patients to minimize the risk of developing diabetes or its complications

Timeline

Start date
2023-04-15
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2023-05-18
Last updated
2023-05-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05864183. Inclusion in this directory is not an endorsement.